相关实验视频

Updated: Jun 20, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

理性设计的高强度NKT细胞激动剂,通过键相互作用具有不同的细胞因子选择性

Yu Wen¹, Dong Ding¹, Meng-Qiang Luo¹

¹National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensing Technology and Health, College of Chemistry, Central China Normal University, Wuhan 430079, China.

Journal of medicinal chemistry

|July 20, 2024

概括

新的合成化合物,GCS-11和GCS-12,是天然杀手T (NKT) 细胞的强有力的激动剂. 这些分子通过改进的甘油脂/CD1d相互作用来选择性地促进抗癌免疫反应来增强免疫疗法.

科学领域:

免疫学免疫学免疫学
药用化学医学化学
药物发现药物发现药物发现

背景情况:

合成的α-galactosylceramide (αGalCer) 类似物对于免疫疗法和辅助剂开发至关重要.
开发强大的NKT细胞激动剂,特别是针对抗癌作用的Th1选择性激动剂,仍然是一个挑战.

研究的目的:

设计和合成具有增强NKT细胞激素活性的新型αGalCer类似物.
研究引入硫胺组对糖脂/CD1d相互作用和细胞因子诱导概况的影响.

主要方法:

化学合成αGalCer类似物,在乙烯链中包含硫胺基.
在体内评估NKT细胞激素激剂功效和合成化合物的细胞因子诱导模式 (IFN-γ,IL-4).
对抗瘤效应的评估.

主要成果:

两种新型化合物,GCS-11和GCS-12,被确定为极强的NKT细胞激动剂.
GCS-11 显示出 Th1 偏差反应,使 IFN-γ 增加了 6 倍,但没有影响 IL-4.
与αGalCer.相比,GCS-12显示Th1/2平衡的反应,增加IFN-γ (7倍) 和IL-4 (5倍) 两者.
这两种化合物都表现出优越的抗瘤作用.

结论:

将硫胺基组引入αGalCer乙烯链增强了甘油脂/CD1d相互作用,从而产生更强大的NKT细胞激动剂.
涉及键衍生是一种有效的策略,用于开发用于免疫治疗的两极化NKT细胞激动剂.
GCS-11和GCS-12是癌症免疫治疗的有希望的候选者,因为它们的效能和独特的细胞因子配置.

更多相关视频

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...